Here's what's behind their impressive market performances.
News & Analysis: Protagonist Therapeutics, Inc. Common Stock
PTGX earnings call for the period ending March 31, 2020.
The company is set to start a pivotal study for one of its lead pipeline candidates.
The remaining weeks of December are chock-full of clinical trial results and FDA approval decisions that savvy investors can take advantage of.
PTGX earnings call for the period ending March 31, 2019.
These stocks missed the rally. Find out why.
Traders rush for the exits after the company announces bad clinical news.